208 related articles for article (PubMed ID: 22890560)
21. MicroRNA 181b promotes vascular smooth muscle cells proliferation through activation of PI3K and MAPK pathways.
Li TJ; Chen YL; Gua CJ; Xue SJ; Ma SM; Li XD
Int J Clin Exp Pathol; 2015; 8(9):10375-84. PubMed ID: 26617745
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of vascular smooth muscle cell proliferation and migration in vitro and neointimal hyperplasia in vivo by adenoviral-mediated atrial natriuretic peptide delivery.
Larifla L; Déprez I; Pham I; Rideau D; Louzier V; Adam M; Eloit M; Foucan L; Adnot S; Teiger E
J Gene Med; 2012 Jul; 14(7):459-67. PubMed ID: 22645072
[TBL] [Abstract][Full Text] [Related]
23. Redox-sensitive transcription factor Nrf2 regulates vascular smooth muscle cell migration and neointimal hyperplasia.
Ashino T; Yamamoto M; Yoshida T; Numazawa S
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):760-8. PubMed ID: 23413426
[TBL] [Abstract][Full Text] [Related]
24. Flow-Dependent Regulation of Kruppel-Like Factor 2 Is Mediated by MicroRNA-92a.
Wu W; Xiao H; Laguna-Fernandez A; Villarreal G; Wang KC; Geary GG; Zhang Y; Wang WC; Huang HD; Zhou J; Li YS; Chien S; Garcia-Cardena G; Shyy JY
Circulation; 2011 Aug; 124(5):633-41. PubMed ID: 21768538
[TBL] [Abstract][Full Text] [Related]
25. Effects of flavonoids on MicroRNA 145 regulation through Klf4 and myocardin in neointimal formation in vitro and in vivo.
Lin CM; Wang BW; Pan CM; Fang WJ; Chua SK; Hou SW; Chang H; Shyu KG
J Nutr Biochem; 2018 Feb; 52():27-35. PubMed ID: 29127880
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-92a -mediated endothelial to mesenchymal transition controls vein graft neointimal lesion formation.
Zhong CM; Li S; Wang XW; Chen D; Jiang ZL; Zhang C; He XJ; Huang C; Jiang YJ; Wu QC
Exp Cell Res; 2021 Jan; 398(1):112402. PubMed ID: 33253710
[TBL] [Abstract][Full Text] [Related]
27. Role of cAMP-phosphodiesterase 1C signaling in regulating growth factor receptor stability, vascular smooth muscle cell growth, migration, and neointimal hyperplasia.
Cai Y; Nagel DJ; Zhou Q; Cygnar KD; Zhao H; Li F; Pi X; Knight PA; Yan C
Circ Res; 2015 Mar; 116(7):1120-32. PubMed ID: 25608528
[TBL] [Abstract][Full Text] [Related]
28. Transplantation of endothelial progenitor cells overexpressing endothelial nitric oxide synthase enhances inhibition of neointimal hyperplasia and restores endothelium-dependent vasodilatation.
Cui B; Huang L; Fang Y; Guo R; Yin Y; Zhao X
Microvasc Res; 2011 Jan; 81(1):143-50. PubMed ID: 20888843
[TBL] [Abstract][Full Text] [Related]
29. Antiproliferative effect of estrogen in vascular smooth muscle cells is mediated by Kruppel-like factor-4 and manganese superoxide dismutase.
Sivritas D; Becher MU; Ebrahimian T; Arfa O; Rapp S; Bohner A; Mueller CF; Umemura T; Wassmann S; Nickenig G; Wassmann K
Basic Res Cardiol; 2011 Jun; 106(4):563-75. PubMed ID: 21484412
[TBL] [Abstract][Full Text] [Related]
30. Site-specific microRNA-92a regulation of Kruppel-like factors 4 and 2 in atherosusceptible endothelium.
Fang Y; Davies PF
Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):979-87. PubMed ID: 22267480
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of vascular smooth muscle cell proliferation and neointimal formation in injured arteries by a novel, oral mitogen-activated protein kinase/extracellular signal-regulated kinase inhibitor.
Gennaro G; Ménard C; Michaud SE; Deblois D; Rivard A
Circulation; 2004 Nov; 110(21):3367-71. PubMed ID: 15520324
[TBL] [Abstract][Full Text] [Related]
32. Cinaciguat prevents neointima formation after arterial injury by decreasing vascular smooth muscle cell migration and proliferation.
Hirschberg K; Tarcea V; Páli S; Barnucz E; Gwanmesia PN; Korkmaz S; Radovits T; Loganathan S; Merkely B; Karck M; Szabó G
Int J Cardiol; 2013 Jul; 167(2):470-7. PubMed ID: 22357420
[TBL] [Abstract][Full Text] [Related]
33. Chrysin boosts KLF2 expression through suppression of endothelial cell-derived exosomal microRNA-92a in the model of atheroprotection.
Lin CM; Wang BW; Pan CM; Fang WJ; Chua SK; Cheng WP; Shyu KG
Eur J Nutr; 2021 Dec; 60(8):4345-4355. PubMed ID: 34041583
[TBL] [Abstract][Full Text] [Related]
34. Protection of endothelial cells, inhibition of neointimal hyperplasia by β-elemene in an injured artery.
Wu L; Wang G; Tang S; Long G; Yin T
Cardiovasc Drugs Ther; 2011 Jun; 25(3):233-42. PubMed ID: 21607546
[TBL] [Abstract][Full Text] [Related]
35. High concentrations of uric acid inhibit angiogenesis via regulation of the Krüppel-like factor 2-vascular endothelial growth factor-A axis by miR-92a.
Yu S; Hong Q; Wang Y; Hou K; Wang L; Zhang Y; Fu B; Zhou Y; Zheng W; Chen X; Wu D
Circ J; 2015; 79(11):2487-98. PubMed ID: 26299712
[TBL] [Abstract][Full Text] [Related]
36. Nobiletin Inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration and attenuates neointimal hyperplasia in a rat carotid artery injury model.
Guan S; Tang Q; Liu W; Zhu R; Li B
Drug Dev Res; 2014 Dec; 75(8):489-96. PubMed ID: 25452110
[TBL] [Abstract][Full Text] [Related]
37. Protease-activated receptor-1 antagonist F 16618 reduces arterial restenosis by down-regulation of tumor necrosis factor α and matrix metalloproteinase 7 expression, migration, and proliferation of vascular smooth muscle cells.
Chieng-Yane P; Bocquet A; Létienne R; Bourbon T; Sablayrolles S; Perez M; Hatem SN; Lompré AM; Le Grand B; David-Dufilho M
J Pharmacol Exp Ther; 2011 Mar; 336(3):643-51. PubMed ID: 21139058
[TBL] [Abstract][Full Text] [Related]
38. Lercanidipine inhibits vascular smooth muscle cell proliferation and neointimal formation via reducing intracellular reactive oxygen species and inactivating Ras-ERK1/2 signaling.
Wu JR; Liou SF; Lin SW; Chai CY; Dai ZK; Liang JC; Chen IJ; Yeh JL
Pharmacol Res; 2009 Jan; 59(1):48-56. PubMed ID: 18973813
[TBL] [Abstract][Full Text] [Related]
39. Endothelial Progenitor Cells Modulate the Phenotype of Smooth Muscle Cells and Increase Their Neointimal Accumulation Following Vascular Injury.
Mause SF; Ritzel E; Deck A; Vogt F; Liehn EA
Thromb Haemost; 2022 Mar; 122(3):456-469. PubMed ID: 34214997
[TBL] [Abstract][Full Text] [Related]
40. Deficiency of MAPK-activated protein kinase 2 (MK2) prevents adverse remodelling and promotes endothelial healing after arterial injury.
Kapopara PR; von Felden J; Soehnlein O; Wang Y; Napp LC; Sonnenschein K; Wollert KC; Schieffer B; Gaestel M; Bauersachs J; Bavendiek U
Thromb Haemost; 2014 Dec; 112(6):1264-76. PubMed ID: 25120198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
